Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €35.32 EUR
Change Today +0.65 / 1.86%
Volume 0.0
AG8 On Other Exchanges
Symbol
Exchange
New York
As of 2:18 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

agilent technologies inc (AG8) Snapshot

Open
€34.71
Previous Close
€34.67
Day High
€35.32
Day Low
€34.70
52 Week High
09/18/14 - €46.45
52 Week Low
12/16/14 - €30.49
Market Cap
11.8B
Average Volume 10 Days
43.6
EPS TTM
--
Shares Outstanding
333.2M
EX-Date
06/26/15
P/E TM
--
Dividend
€0.40
Dividend Yield
1.04%
Current Stock Chart for AGILENT TECHNOLOGIES INC (AG8)

agilent technologies inc (AG8) Details

Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company’s Life Sciences and Diagnostics segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems; immunohistochemistry; in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation and gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems. Its Chemical Analysis segment provides gas chromatography systems, columns, and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; inductively coupled plasma optical emission spectrometry instruments; molecular spectroscopy instruments; software and data systems; and vacuum pumps and measurement technologies. Agilent Technologies, Inc. sells its products through direct sales; and distributors, resellers, manufacturer's representatives, telesales, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.

11,600 Employees
Last Reported Date: 06/5/15
Founded in 1999

agilent technologies inc (AG8) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $606.3K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $600.0K
Executive Vice President, Chief Executive Off...
Total Annual Compensation: $795.8K
Senior Advisor
Total Annual Compensation: $1.1M
Compensation as of Fiscal Year 2014.

agilent technologies inc (AG8) Key Developments

Agilent Technologies Launches New Products for Analyzing Biotherapeutics

Agilent Technologies Inc. announced two additions to its AdvanceBio product family, designed to provide rapid, reproducible results for scientists in the biopharmaceutical industry. Agilent introduced the products—the AdvanceBio glycan-mapping workflow and the AdvanceBio oligonucleotide column—at HPLC 2015, an international symposium being held in Geneva, Switzerland, this week. The company’s new AdvanceBio glycan-mapping workflow is a complete consumables workflow for deglycosylation, 2-AB labeling and HILIC glycan analysis using mass spectrometry and fluorescence detection. This unique workflow features AdvanceBio glycan-mapping columns, glycan standards and N-glycan sample-preparation kits, along with all the consumable components researchers require. The product’s comprehensive guides and standard methods provide researchers with everything they need to quickly identify and quantify glycans in a way that is easily reproducible.

Agilent Technologies Inc. Introduces Second Automatic Sampler for 1290 Infinity II LC System

Agilent Technologies Inc. introduced a second automatic sampler for its ultra-high-performance 1290 Infinity II LC system. The new 1290 Infinity II Vialsampler shortens injection cycles, lowers carryover and enlarges sample capacity at a pressure range of up to 1300 bar. The new module is being shown for the first time at HPLC 2015, an international symposium on high-performance liquid phase separations and related techniques, in Geneva, Switzerland. Highly integrated, the new module combines autosampler features with options to integrate both a column oven and a sample cooler. It offers analytical laboratories a cost-effective way to experience the advantages of ultra-high-pressure liquid chromatography.

Agilent Technologies Announces Updates to SurePrint Gene Expression Microarrays

Agilent Technologies Inc. has announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the updates to its SurePrint G3 Human v3 gene expression microarray in collaboration with Ghent University for complete coverage of the LNCipedia 2.1 database to assay high-confidence, long noncoding RNA (lncRNA) transcripts. LncRNAs (noncoding RNA longer than 200 nucleotides) modify gene regulation through direct interactions with DNA, RNA and proteins to enable target-specific or system-wide modulation. The broad but critical role of lncRNAs can be seen in their association with cancer, cardiovascular and neurodegenerative diseases. Agilent's redesigned gene expression microarrays are high-quality signature capture tools for efficient analysis of genes or pathways of interest with broad applications that range from aiding in disease stratification to elucidating drug mechanisms. Measuring both types of RNA in a single assay provides insight into the biological association between mRNA and lncRNA from relative expression levels. The key is having a good balance of coding and long noncoding features, and LNCipedia 2.1 is an optimal source to pair with Agilent's gene expression content.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG8:GR €35.32 EUR +0.65

AG8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $55.50 USD +0.72
ARRIS Group Inc $30.41 USD -0.19
Furukawa Electric Co Ltd ¥219.00 JPY +1.00
NVIDIA Corp $20.40 USD +0.29
STMicroelectronics NV €7.38 EUR +0.02
View Industry Companies
 

Industry Analysis

AG8

Industry Average

Valuation AG8 Industry Range
Price/Earnings 24.5x
Price/Sales 1.9x
Price/Book 3.1x
Price/Cash Flow 39.7x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILENT TECHNOLOGIES INC, please visit www.home.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.